Evidence map›Paper›PMID 37604476›Full record

ArticleThe American journal of tropical medicine and hygiene2025

Process and Methodological Considerations for Observational Analyses of Vector Control Interventions in Sub-Saharan Africa Using Routine Malaria Data.

Sarah M Burnett, Kelly M Davis, Gudissa Assefa, Christelle Gogue, Levi D Hinneh, Megan Littrell, Julia Mwesigwa, Okefu O Okoko, Saraha Rabeherisoa, Musa Sillah-Kanu and 6 more

Open access · hybridAbstract read
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Harnessing Malaria Surveillance Data for Transformative Malaria Control and Elimination.The American journal of tropical medicine and hygiene · 2025
    Article
  4. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 5 countries.

Sarah M BurnettU.S. President's Malaria Initiative (PMI) VectorLink Project, PATH, Washington, District of Columbia.
Kelly M DavisU.S. President's Malaria Initiative (PMI) VectorLink Project, PATH, Washington, District of Columbia.
Gudissa AssefaNational Malaria Elimination Programme, Addis Ababa, Ethiopia.
Christelle GogueNew Nets Project, PATH, Seattle, Washington.
Levi D HinnehNational Malaria Control Programme, Monrovia, Liberia.
Megan LittrellPATH, Seattle, Washington.
Julia MwesigwaNew Nets Project, PATH, Kampala, Uganda.
Okefu O OkokoNational Malaria Elimination Programme, Abuja, Nigeria.
Saraha RabeherisoaProgramme National de Lutte Contre le Paludisme, Antananarivo, Madagascar.
Musa Sillah-KanuNational Malaria Control Program, Freetown, Sierra Leone.
William SheahanPATH, Seattle, Washington.
Hannah C SlaterPATH, Seattle, Washington.
Perpetua UhomoibhiNational Malaria Elimination Programme, Abuja, Nigeria.
Frederick YambaNational Malaria Control Program, Freetown, Sierra Leone.
Kelley AmbrosePresident's Malaria Initiative (PMI) VectorLink Project, Abt Associates, Rockville, Maryland.
Kathryn StillmanPresident's Malaria Initiative (PMI) VectorLink Project, Abt Associates, Rockville, Maryland.
Program for Appropriate Technology in Health · USAbt Global (United States) · USAIDS Prevention Initiative in Nigeria · NGSierra Leone Urban Research Centre · SLNational Application Center for Pharmaceutical Research · MGNational Public Health Institute of Liberia · LRU.S. President's Malaria Initiative · USVector (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Progress in malaria control has stalled in recent years. With growing resistance to existing malaria vector control insecticides and the introduction of new vector control products, national malaria control programs (NMCPs) increasingly need to make data-driven, subnational decisions to inform vector control deployment. As NMCPs are increasingly conducting subnational stratification of malaria control interventions, including malaria vector control, country-specific frameworks and platforms are increasingly needed to guide data use for vector control deployment. Integration of routine health systems data, entomological data, and vector control program data in observational longitudinal analyses offers an opportunity for NMCPs and research institutions to conduct evaluations of existing and novel vector control interventions. Drawing on the experience of implementing 22 vector control evaluations across 14 countries in sub-Saharan Africa, as well as published and gray literature on vector control impact evaluations using routine health information system data, this article provides practical guidance on the design of these evaluations, makes recommendations for key variables and data sources, and proposes methods to address challenges in data quality. Key recommendations include appropriate parameterization of impact and coverage indicators, incorporating explanatory covariates and contextual factors from multiple sources (including rapid diagnostic testing stockouts; insecticide susceptibility; vector density measures; vector control coverage, use, and durability; climate and other malaria and non-malaria health programs), and assessing data quality before the evaluation through either on-the-ground or remote data quality assessments. These recommendations may increase the frequency, rigor, and utilization of routine data sources to inform national program decision-making for vector control.

Indexed as

MalariaMosquito ControlMosquito VectorsAfrica South of the SaharaAnimalsHumansInsecticidesInsecticides

Identifiers

PMID37604476
PMCPMC11720682
OpenAlexW4386026597

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.